Over the course of the COVID-19 pandemic, numerous studies have aimed to address the
challenges faced by patients with kidney disease and their caregivers. These studies …

Importance There is a need for studies to evaluate the risk factors for COVID-19 and
mortality among the entire Medicare long-term dialysis population using Medicare claims …

Results SARS-CoV-2 infection was identified in 1323 patients of different ethnicities
(Asian/other, 30%; Black, 38%; and White, 32%), including 1047 (79%) unvaccinated, 86 …

Introduction Following the first wave of COVID‐19 there have been several variants. We
wished to review the number and severity of infections with the different variants in a …

Introduction To assess the impact of the COVID-19 pandemic impact on hemodialysis (HD)
centers, The Dialysis Outcomes and Practice Patterns Study and ISN collaborated on a web …

Background Hemodialysis patients are at high risk of Covid-19, though vaccination has
significant efficacy in preventing and reducing the severity of infection. Little information is …

Background Molnupiravir is an essential oral antiviral agent against coronavirus disease
2019 (COVID-19); however, its real-world effectiveness has not been evaluated in patients …

Background COVID-19 is associated with increased morbidity and mortality in patients with
end-stage kidney disease on dialysis. Efficacy of SARS-CoV-2 vaccination to prevent severe …

Introduction Hemodialysis (HD) patients are a COVID-19 high risk population due to
comorbidities and impaired immune response. Vaccines, advent of effective treatment and …

The aim of this study was to evaluate the risk of COVID-19 in end-stage renal disease
(ESRD) patients, the cost burden of the COVID-19 pandemic on the management of ESRD …